Basket

  Untick selected:   0
  1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or IImyeloid cells surface antigens [II] CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)  / Drgoňa L. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 13, č. 3 (2018), s. 221  
    C 3069
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.